Community-based prevalence and associated factors of sarcopenia in the Vietnamese elderly

被引:0
作者
Lan-Anh Thi Pham
Binh Thanh Nguyen
Dao Tieu Huynh
Binh-Minh Le Thi Nguyen
Phuong-Anh Nhat Tran
Tam Van Vo
Hy-Han Thi Bui
Truc Thanh Thai
机构
[1] University of Medicine and Pharmacy at Ho Chi Minh City,Department of Nutrition and Food
[2] Tra Vinh University,Department of Medicine and Pharmacy
[3] University of Medicine and Pharmacy at Ho Chi Minh City,Faculty of Public Health
[4] University Medical Center Ho Chi Minh City,Laboratory Department
来源
Scientific Reports | / 14卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Sarcopenia, a condition characterized by muscle mass decline, is one of the leading health problems in the elderly. This study determined the rate of sarcopenia according to criteria by Asian Working Group for Sarcopenia (AWGS) and related factors in elderly people. A community-based cross-sectional study was conducted in 632 people aged 60 years or over in Ho Chi Minh City. Data were collected through a predefined questionnaire and direct measurement. Sarcopenia was identified based on the Inbody 770 machine and AWGS criteria. The prevalence of sarcopenia was 32.0%. Participants with advanced age, low education, unemployment, low level of family economics and frailty were more likely to have sarcopenia. Among these, frailty had the highest impact on sarcopenia, with significantly higher odds of having sarcopenia found in participants with pre-frailty (OR = 4.80, 95% CI 2.75–8.38, p < 0.001) and frailty (OR = 21.16, 95% CI 8.96–49.97, p < 0.001). In contrast, BMI was inversely associated with sarcopenia. Sarcopenia is prevalent in the Vietnamese elderly. Apart from social demographic characteristics including age, education, employment and family economic status, frailty appeared to be an important risk factor. Early screening, referral, and treatment of sarcopenia among the elderly having a high risk of sarcopenia are recommended.
引用
收藏
相关论文
共 39 条
  • [1] Morley JE(2001)Sarcopenia J. Lab. Clin. Med. 137 231-243
  • [2] Baumgartner RN(2010)Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People Age Ageing 39 412-423
  • [3] Roubenoff R(2017)Prevalence of sarcopenia in the world: A systematic review and meta-analysis of general population studies J. Diabetes Metab. Disord. 16 1-10
  • [4] Mayer J(2014)Clinical definition of sarcopenia Clin. Cases Miner. Bone Metab. 11 177-658
  • [5] Nair KS(2012)Sarcopenia as a risk factor for falls in elderly individuals: Results from the ilSIRENTE study Clin. Nutr. 31 652-126
  • [6] Cruz-Jentoft AJ(2012)Sarcopenia and mortality among older nursing home residents J. Am. Med. Directors Assoc. 13 121-258
  • [7] Shafiee G(2017)Sarcopenia predicts readmission and mortality in elderly patients in acute care wards: A prospective study J. Cachexia Sarcopenia Muscle. 8 251-172
  • [8] Santilli V(2019)Sarcopenia Wiener Medizinische Wochenschrift. 169 157-383
  • [9] Bernetti A(2010)Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy Ageing Res. Rev. 9 369-33
  • [10] Mangone M(2008)The role of mitochondrial DNA mutations in aging and sarcopenia: Implications for the mitochondrial vicious cycle theory of aging Exp. Gerontol. 43 24-1860